FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043871808> ?p ?o ?g. }

• W3043871808 endingPage "249" @default.
• W3043871808 startingPage "249" @default.
• W3043871808 abstract "<h3>Importance</h3> Thyroid hormones play a key role in modulating myocardial contractility. Subclinical hypothyroidism in patients with acute myocardial infarction is associated with poor prognosis. <h3>Objective</h3> To evaluate the effect of levothyroxine treatment on left ventricular function in patients with acute myocardial infarction and subclinical hypothyroidism. <h3>Design, Setting, and Participants</h3> A double-blind, randomized clinical trial conducted in 6 hospitals in the United Kingdom. Patients with acute myocardial infarction including ST-segment elevation and non–ST-segment elevation were recruited between February 2015 and December 2016, with the last participant being followed up in December 2017. <h3>Interventions</h3> Levothyroxine treatment (n = 46) commencing at 25 µg titrated to aim for serum thyrotropin levels between 0.4 and 2.5 mU/L or identical placebo (n = 49), both provided in capsule form, once daily for 52 weeks. <h3>Main Outcomes and Measures</h3> The primary outcome measure was left ventricular ejection fraction at 52 weeks, assessed by magnetic resonance imaging, adjusted for age, sex, type of acute myocardial infarction, affected coronary artery territory, and baseline left ventricular ejection fraction. Secondary measures were left ventricular volumes, infarct size (assessed in a subgroup [n = 60]), adverse events, and patient-reported outcome measures of health status, health-related quality of life, and depression. <h3>Results</h3> Among the 95 participants randomized, the mean (SD) age was 63.5 (9.5) years, 72 (76.6%) were men, and 65 (69.1%) had ST-segment elevation myocardial infarction. The median serum thyrotropin level was 5.7 mU/L (interquartile range, 4.8-7.3 mU/L) and the mean (SD) free thyroxine level was 1.14 (0.16) ng/dL. The primary outcome measurements at 52 weeks were available in 85 patients (89.5%). The mean left ventricular ejection fraction at baseline and at 52 weeks was 51.3% and 53.8%, respectively, in the levothyroxine group compared with 54.0% and 56.1%, respectively, in the placebo group (adjusted difference in groups, 0.76% [95% CI, −0.93% to 2.46%];<i>P</i> = .37). None of the 6 secondary outcomes showed a significant difference between the levothyroxine and placebo treatment groups. There were 15 (33.3%) and 18 (36.7%) cardiovascular adverse events in the levothyroxine and placebo groups, respectively. <h3>Conclusions and Relevance</h3> In this preliminary study involving patients with subclinical hypothyroidism and acute myocardial infarction, treatment with levothyroxine, compared with placebo, did not significantly improve left ventricular ejection fraction after 52 weeks. These findings do not support treatment of subclinical hypothyroidism in patients with acute myocardial infarction. <h3>Trial Registration</h3> isrctn.org Identifier:http://www.isrctn.com/ISRCTN52505169" @default.
• W3043871808 created "2020-07-29" @default.
• W3043871808 creator A5004676254 @default.
• W3043871808 creator A5010281009 @default.
• W3043871808 creator A5013617812 @default.
• W3043871808 creator A5015042963 @default.
• W3043871808 creator A5023057149 @default.
• W3043871808 creator A5025533488 @default.
• W3043871808 creator A5036682346 @default.
• W3043871808 creator A5038848300 @default.
• W3043871808 creator A5039379170 @default.
• W3043871808 creator A5044646526 @default.
• W3043871808 creator A5064428389 @default.
• W3043871808 creator A5075086360 @default.
• W3043871808 creator A5081730199 @default.
• W3043871808 creator A5089617303 @default.
• W3043871808 date "2020-07-21" @default.
• W3043871808 modified "2023-10-18" @default.
• W3043871808 title "Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction" @default.
• W3043871808 cites W1488262221 @default.
• W3043871808 cites W179414209 @default.
• W3043871808 cites W1820889844 @default.
• W3043871808 cites W1977065440 @default.
• W3043871808 cites W1984273763 @default.
• W3043871808 cites W1994316999 @default.
• W3043871808 cites W2001491679 @default.
• W3043871808 cites W2028273454 @default.
• W3043871808 cites W2049307843 @default.
• W3043871808 cites W2050302634 @default.
• W3043871808 cites W2068309857 @default.
• W3043871808 cites W2081641269 @default.
• W3043871808 cites W2093505519 @default.
• W3043871808 cites W2096560123 @default.
• W3043871808 cites W2108202942 @default.
• W3043871808 cites W2110352248 @default.
• W3043871808 cites W2123066698 @default.
• W3043871808 cites W2128219988 @default.
• W3043871808 cites W2136006969 @default.
• W3043871808 cites W2148502290 @default.
• W3043871808 cites W2150214049 @default.
• W3043871808 cites W2152277743 @default.
• W3043871808 cites W2260017177 @default.
• W3043871808 cites W2547458640 @default.
• W3043871808 cites W2548036931 @default.
• W3043871808 cites W2611937454 @default.
• W3043871808 cites W2752734847 @default.
• W3043871808 cites W2778174446 @default.
• W3043871808 cites W2782452982 @default.
• W3043871808 cites W2800087803 @default.
• W3043871808 cites W2800239085 @default.
• W3043871808 cites W2888295153 @default.
• W3043871808 cites W2903614523 @default.
• W3043871808 cites W2904496087 @default.
• W3043871808 cites W2945825315 @default.
• W3043871808 cites W2991196305 @default.
• W3043871808 cites W4245500425 @default.
• W3043871808 cites W4292528167 @default.
• W3043871808 cites W4292856638 @default.
• W3043871808 doi "https://doi.org/10.1001/jama.2020.9389" @default.
• W3043871808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32692386" @default.
• W3043871808 hasPublicationYear "2020" @default.
• W3043871808 type Work @default.
• W3043871808 sameAs 3043871808 @default.
• W3043871808 citedByCount "29" @default.
• W3043871808 countsByYear W30438718082020 @default.
• W3043871808 countsByYear W30438718082021 @default.
• W3043871808 countsByYear W30438718082022 @default.
• W3043871808 countsByYear W30438718082023 @default.
• W3043871808 crossrefType "journal-article" @default.
• W3043871808 hasAuthorship W3043871808A5004676254 @default.
• W3043871808 hasAuthorship W3043871808A5010281009 @default.
• W3043871808 hasAuthorship W3043871808A5013617812 @default.
• W3043871808 hasAuthorship W3043871808A5015042963 @default.
• W3043871808 hasAuthorship W3043871808A5023057149 @default.
• W3043871808 hasAuthorship W3043871808A5025533488 @default.
• W3043871808 hasAuthorship W3043871808A5036682346 @default.
• W3043871808 hasAuthorship W3043871808A5038848300 @default.
• W3043871808 hasAuthorship W3043871808A5039379170 @default.
• W3043871808 hasAuthorship W3043871808A5044646526 @default.
• W3043871808 hasAuthorship W3043871808A5064428389 @default.
• W3043871808 hasAuthorship W3043871808A5075086360 @default.
• W3043871808 hasAuthorship W3043871808A5081730199 @default.
• W3043871808 hasAuthorship W3043871808A5089617303 @default.
• W3043871808 hasBestOaLocation W30438718081 @default.
• W3043871808 hasConcept C113280763 @default.
• W3043871808 hasConcept C126322002 @default.
• W3043871808 hasConcept C164705383 @default.
• W3043871808 hasConcept C2775883008 @default.
• W3043871808 hasConcept C2778198053 @default.
• W3043871808 hasConcept C500558357 @default.
• W3043871808 hasConcept C526584372 @default.
• W3043871808 hasConcept C71924100 @default.
• W3043871808 hasConcept C78085059 @default.
• W3043871808 hasConceptScore W3043871808C113280763 @default.
• W3043871808 hasConceptScore W3043871808C126322002 @default.
• W3043871808 hasConceptScore W3043871808C164705383 @default.
• W3043871808 hasConceptScore W3043871808C2775883008 @default.
• W3043871808 hasConceptScore W3043871808C2778198053 @default.

• next